***Bioscience Career Seminar Series***
Presents:
"Biology is Technology: The Promise, Peril, and New Business of Engineering Life."
Rob Carlson, Ph.D.
BioDesic
*Refreshments and Snacks Provided*
Thursday, October 21st, 5-6pm, UW, Health Science Building
Room T-739 (T-wing)
Biotechnology is developing at a remarkable rate. Reading and writing DNA are both experiencing exponential improvements in cost and productivity due to advances in methods and automation. As of 2008, US revenues from the products of genetically modified systems were equivalent to approximately 2% of GDP, and were growing at about 15% annually. The future holds new drugs, treatments, fuels, materials, and crops, all produced using biological technologies.
Despite these rapid changes, the engineering of biology remains very difficult and typically does not result in systems with behaviors that are as predictable as airplanes, computers, or automobiles. A great deal of investment and effort is presently engaged in attempting to place biological engineering on the same footing. The promise of this project is great, as are the perils, and there is no guarantee of success.
For the schedule of future speakers and other resources check out our website: http://courses.washington.edu/phd/
